Dermatology Access> Search results

Thomson Reuters

Infection

Please find below AccessDermatology content related to the keyword: Infection

Clinical Trials including "Infection"

Ceftaroline vs. vancomycin plus aztreonam in complicated skin and skin structure infections: The CANVAS-1 (CeftAroliNe versus VAncomycin in Skin and skin structure infections 1; NCT00424190) study
Summary
CANVAS 1: The first Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
Ceftaroline vs. vancomycin plus aztreonam in complicated skin and skin structure infections: The CANVAS-2 (CeftAroliNe versus VAncomycin in Skin and skin structure infections 2; NCT00423657) study
Summary
CANVAS 2: The second Phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections
Fluconazole vs. flutrimazole in cutaneous dermatomycosis
Summary
Study to compare the efficacy and safety of fluconazole cream with flutrimazole cream in the treatment of superficial mycosis: A multicentre, randomised, double-blind, phase III trial
Telavancin vs. vancomycin in cellulitis/infected ulcers: The ATLAS 1 & 2 (Assessment of TeLAvancin in Skin and skin structure infections) studies
Summary
Telavancin for the treatment of cellulitis and infected ulcers
Telavancin vs. vancomycin in cellulitis/infected ulcers: The ATLAS 1 & 2 (Assessment of TeLAvancin in Skin and skin structure infections) studies
Summary
Telavancin for the treatment of cellulitis and infected ulcers

Last updated: Wednesday, April 18, 2012

AccessDermatology | © Copyright 2012 Prous Science S.A.U. a Thomson Reuters business or its licensors. All rights reserved. Legal Information. Send your comments to Webmaster
ISSN 2013-8202

This website is optimized for Explorer 7.0 and above, Firefox 3.0, Safari, and Chrome. Content remains viewable in older versions, but loss of formatting and design elements may occur.

This site complies with the HONcode standard for trustworthy health information:
verify here.